APOE and triple-A syndrome: To determine the effect of BMT on the development of AAA, we infused Angiotensin II (Ang II) at 0.8 mg/kg/day using subcutaneous mini pumps in male ApoE−/− mice that had undergone BMT and matched control non-BMT animals over 14 days.